Group controlled by Patrice Debregeas

DBT Pharma, also known as Debregeas & Associés Pharma, is a French pharmaceutical group founded in 1990 by Patrice Debrégeas. The company operates as a specialty pharmaceutical laboratory and a Contract Development and Manufacturing Organization (CDMO) specializing in complex oral solid dosage forms. It is particularly recognized for its proprietary expertise in pelletization and sustained-release technologies, such as microgranules, which optimize drug delivery and patient compliance. The group manages the entire drug lifecycle, from formulation and R&D to industrial manufacturing and international distribution in over 50 countries. With its main manufacturing site in Nogent-le-Phaye, France, DBT Pharma provides high-quality GMP-compliant services to global pharmaceutical partners.